3D Systems (DDD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Supplement updates voting recommendations, by-law amendment, and corrects share count for the 2026 Annual Meeting.
ISS recommends voting for all director nominees, executive compensation, auditor ratification, and share increase, but against the Equity Plan Proposal.
Board disagrees with ISS on the Equity Plan Proposal, emphasizing its importance for talent retention and cost restructuring.
Correction issued for the number of shares outstanding as of the record date: 146,057,215 shares.
Ongoing shareholder engagement and outreach efforts are highlighted.
Voting matters and shareholder proposals
ISS recommends voting for all nine director nominees, executive compensation, auditor ratification, and share increase.
ISS recommends voting against the Equity Plan Proposal due to concerns over plan cost, burn rate, share recycling, and vesting discretion.
Board urges shareholders to vote for all proposals, especially the Equity Plan Proposal.
Board of directors and corporate governance
Board adopted amended and restated by-laws to clarify voting standards, aligning with Delaware law; no substantive change to voting standards.
Latest events from 3D Systems
- Proxy covers director elections, compensation, auditor, share increase, and incentive plan changes.DDD
Proxy filing8 Apr 2026 - Proxy seeks approval for board elections, compensation, auditor, share increase, and incentive plan.DDD
Proxy filing26 Mar 2026 - Q4 2025 saw 16% sequential growth, margin gains, and $55M in cost savings, led by key segments.DDD
Q4 20259 Mar 2026 - Q2 revenue rose sequentially, margin improved, and full-year outlook targets breakeven Q4.DDD
Q2 202422 Jan 2026 - FDA-approved 3D printed dentures and aerospace growth position the business for major expansion.DDD
28th Annual Needham Growth Conference Virtual13 Jan 2026 - Q3 revenue fell 9% YoY to $112.9M, with a $178.6M net loss from impairment charges.DDD
Q3 202412 Jan 2026 - Aggressive cost actions and R&D focus position the business for growth in key markets.DDD
27th Annual Needham Growth Conference10 Jan 2026 - Dental and healthcare 3D printing lead growth, with cost control and new products driving profitability.DDD
Cantor Fitzgerald Global Technology Conference26 Dec 2025 - 2024 revenue hit $440M; cost cuts and Geomagic sale target break-even EBITDA by Q4 2025.DDD
Q4 20241 Dec 2025